Anti COVID Drug 2-DG First Batch Released By Govt

• ByStartupStory     |    May 17, 2021

The first batch of anti COVID drug 2-DG, developed by the DRDO was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.

The anti COVID drug 2-DG was approved by the Drugs Controller General of India (DGCI) for emergency use earlier this month, as an adjunct therapy in moderate to severe coronavirus patients.

The anti-COVID-19 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) a leading laboratory of DRDO in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.

The defence ministry on May 8 said the clinical trials of the anti COVID drug 2-DG drug showed it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

The anti COVID drug 2-DG drug comes in powder form in a sachet and is taken orally by dissolving it in water, the ministry said.

In efficacy trends, the ministry said, patients treated with anti COVID drug 2-DG showed faster symptomatic cure than the standard of care (SoC) on various endpoints.

In his brief remarks, the defence minister said the anti COVID drug 2-DG has brought a new ray of hope for the treatment of COVID-19 patients.

Follow Startup Story